Safety of Cyclosporin A in HCV-Infected Patients: Experience with Cyclosporin A in Patients Affected by Rheumatological Disorders and Concomitant HCV Infection-Reference-Cited by-同舟云学术

Safety of Cyclosporin A in HCV-Infected Patients: Experience with Cyclosporin A in Patients Affected by Rheumatological Disorders and Concomitant HCV Infection

Published:2007-09-01 Issue:1 Volume:1110 Page:544-549
ISSN:0077-8923
Container-title:Annals of the New York Academy of Sciences
language:en
Short-container-title:Annals of the New York Academy of Sciences

Author:

GALEAZZI M.,BELLISAI F.,GIANNITTI C.,MANGANELLI S.,MOROZZI G.,SEBASTIANI G. D.

Publisher

Wiley

Subject

History and Philosophy of Science,General Biochemistry, Genetics and Molecular Biology,General Neuroscience

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1196/annals.1423.058/fullpdf

Reference18 articles.

1. Cyclosporine A for the treatment of autoimmune disorders in HCV infected patients

2. Long-term administration of cyclosporin A to HCV-antibody-positive patients with dermatologic diseases

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Liver disease among patients with psoriasis: the Malaysian Psoriasis Registry;Clinical and Experimental Dermatology;2023-01-12

2. Infection risk in patients undergoing treatment for inflammatory arthritis: non-biologics versus biologics;Expert Review of Clinical Immunology;2020-01-11

3. Managing Psoriasis in Patients with HBV or HCV Infection: Practical Considerations;American Journal of Clinical Dermatology;2019-06-20

4. Autophagy: A new concept in autoimmunity regulation and a novel therapeutic option;Journal of Autoimmunity;2018-11

5. The Use of Cyclosporine A in Rheumatology: a 2016 Comprehensive Review;Clinical Reviews in Allergy & Immunology;2016-08-11